MindWalk Holdings (HYFT) Cash & Equivalents Growth (1y) (2021 - 2026)
MindWalk Holdings (HYFT) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 23.56% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.05% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 71.81% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 84.98% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 10.29% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 28.50% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 53.39% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -57.58% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 10.29% |
| Jan 31, 2026 | 10.68% |
| Oct 31, 2025 | 348.79% |
| Jul 31, 2025 | 22.00% |
| Apr 30, 2025 | 190.28% |
| Jan 31, 2025 | 96.92% |
| Oct 31, 2024 | -41.10% |
| Jul 31, 2024 | -42.77% |
| Apr 30, 2024 | -57.71% |
| Jan 31, 2024 | -45.00% |
| Oct 31, 2023 | -60.30% |
| Jul 31, 2023 | -65.88% |
| Apr 30, 2023 | -73.94% |
| Jan 31, 2023 | -67.54% |
| Oct 31, 2022 | -62.84% |
| Jul 31, 2022 | -54.84% |
| Apr 30, 2022 | -28.61% |
| Jan 31, 2022 | 113.28% |
| Oct 31, 2021 | 139.56% |
| Apr 30, 2021 | 1,596.80% |